AKT1 and Miyoshi myopathy: CK1a is known to facilitate MM pathogenesis as it sustains activation of oncogenic cascades through p53 activation, phosphoinositide-3-kinase (PI3K) / protein kinase B (AKT) and nuclear factor kappa B (NF-κB) activation and modulation of interferon (IFN) pathway (12, 13).